866-997-4948(US-Canada Toll Free)

Mycosis Fungoides Global Clinical Trials Review, H1, 2018

Published By :

N/A

Published Date : Mar 2018

Category :

Pharmaceutical

No. of Pages : 167 Pages

Mycosis Fungoides Global Clinical Trials Review, H1, 2018

Summary

GlobalData's clinical trial report, Mycosis Fungoides Global Clinical Trials Review, H1, 2018" provides an overview of Mycosis Fungoides clinical trials scenario. This report provides top line data relating to the clinical trials on Mycosis Fungoides. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Mycosis Fungoides to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Mycosis Fungoides to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Mycosis Fungoides Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Mycosis Fungoides 30
Feb 02, 2018: miRagen Therapeutics Presents New Data from Phase 1 Clinical Trial of MRG-106 in Mycosis Fungoides at the T-Cell Lymphoma Forum 30
Jan 24, 2018: miRagen Therapeutics to Present New MRG-106 Phase 1 Clinical Trial Data at the T-Cell Lymphoma Forum 30
Dec 11, 2017: miRagen Therapeutics Presents New Interim Clinical Data Expanding on Previous Data Suggesting Positive Impact From Systemically Administered MRG-106 on Mycosis Fungoides Form of Cutaneous T-Cell Lymphoma at 2017 American Society of Hematology Annual Meeting 31
Dec 11, 2017: Trillium Therapeutics Provides Update on Its TTI-621 Program at the American Society of Hematology 59th Annual Meeting 31
Dec 09, 2017: Seattle Genetics Highlights Updated Analyses from Phase 3 ALCANZA Clinical Trial of ADCETRIS (Brentuximab Vedotin) in CD30-Expressing Cutaneous T-Cell Lymphoma at ASH Annual Meeting 32
Clinical Trial Profile Snapshots 34
Appendix 164
Abbreviations 164
Definitions 164
Research Methodology 165
Secondary Research 165
About GlobalData 166
Contact Us 166
Disclaimer 166
Source 167

List of Tables
Mycosis Fungoides Therapeutics, Global, Clinical Trials by Region, 2018* 7
Mycosis Fungoides Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Mycosis Fungoides Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Mycosis Fungoides Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10
Mycosis Fungoides Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11
Mycosis Fungoides Therapeutics Clinical Trials, North America, Top Countries, 2018* 12
Mycosis Fungoides Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 13
Mycosis Fungoides Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 14
Proportion of Mycosis Fungoides to Oncology Clinical Trials, G7 Countries (%), 2018* 15
Mycosis Fungoides Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Mycosis Fungoides Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Mycosis Fungoides to Oncology Clinical Trials, E7 Countries (%), 2018* 18
Mycosis Fungoides Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Mycosis Fungoides Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
Mycosis Fungoides Therapeutics, Global, Clinical Trials by Phase, 2018* 21
Mycosis Fungoides Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22
Mycosis Fungoides Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Mycosis Fungoides Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Mycosis Fungoides Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Mycosis Fungoides Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
Mycosis Fungoides Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Mycosis Fungoides Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
Mycosis Fungoides Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

List of Figures
Mycosis Fungoides Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Mycosis Fungoides Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Mycosis Fungoides Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Mycosis Fungoides Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10
Mycosis Fungoides Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11
Mycosis Fungoides Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12
Mycosis Fungoides Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 13
Mycosis Fungoides Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 14
Proportion of Mycosis Fungoides to Oncology Clinical Trials, G7 Countries (%), 2018* 15
Mycosis Fungoides Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Mycosis Fungoides Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Mycosis Fungoides to Oncology Clinical Trials, E7 Countries (%), 2018* 18
Mycosis Fungoides Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Mycosis Fungoides Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
Mycosis Fungoides Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21
Mycosis Fungoides Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22
Mycosis Fungoides Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Mycosis Fungoides Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Mycosis Fungoides Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Mycosis Fungoides Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
Mycosis Fungoides Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Mycosis Fungoides Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
Mycosis Fungoides Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29
GlobalData Methodology 165

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *